ArticleJACC. Case reports2026
Discordant Cardiomyopathy Phenotypes in Siblings With Homozygous FKRP c.1100T>C.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPathogenic FKRP variants cause limb-girdle muscular dystrophy R9, with variable cardiac involvement. How genotype influences the cardiac phenotype remains poorly defined for non-European founder variants. CASE SUMMARY: We report 2 siblings of South African Afrikaner descent, both homozygous for FKRP c.1100T>C (p.Ile367Thr), with discordant cardiac phenotypes. The brother (age 25 years) presented at age 17 with nondilated cardiomyopathy (left ventricular ejection fraction [LVEF]: 41%) that progressed to dilated cardiomyopathy, with fibrosis involving 12 to 14 of 17 AHA (American Heart Association) segments late gadolinium enhancement segments over 7 years despite partial reverse remodeling. His sister (age 30 years) had nondilated cardiomyopathy with preserved LVEF (59%) and stable fibrosis in 4 lateral segments over 2 years. DISCUSSION: Serial cardiac magnetic resonance revealed dissociation between functional recovery and fibrosis progression: LVEF improved on guideline-directed therapy, while fibrosis burden remained extensive. TAKE-HOME MESSAGES: Ejection fraction alone underestimates disease progression in FKRP-related cardiomyopathy. Serial cardiac magnetic resonance with late gadolinium enhancement should guide surveillance, especially in non-c.826C>A genotypes where cardiac onset occurs decades earlier.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.